Hi all!
The new AASLD (American Association for the Study of Liver Diseases) Practice Guidelines for the treatment of hepatitis C for genotype 1 patients is now available.
"Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic,
therapeutic, and preventive aspects of care. They are intended to be flexible, in contrast to standards of
care, which are inflexible policies to be followed in every case. Specific recommendations are based on
relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a Class (reflecting benefit versus risk) and Level (assessing strength or certainty) of Evidence to be assigned and reported with each recommendation."
http://www.aasld.org/practiceguidelines/Documents/2011UpdateGenotype1HCVbyAASLD24641.pdf
Enjoy!
Hector